Rising number of minimally invasive surgeries and neurovascular neuroradiology procedures According to the Centers for Disease Control and Prevention, about 87% of all strokes are ischemic strokes and around 10% of these strokes result in death within a period of one month. According to the American Stroke Association, the annual stroke prevalence in the US reach around 800,000 – resulting in approximately 130,000 deaths, every year. The World Health Organization claims that one death by stroke occurs every 10 seconds around the world. The rising prevalence of neurovascular diseases, especially strokes & cerebral infarctions, and the requirement of surgical procedures, are expected to drive the neurovascular guidewire market. More than 50 million surgical procedures were performed in the US in 2016 and every year, the number of surgical procedures is growing. Moreover, the preference for minimally invasive surgeries is increasing. Neurovascular guidewires are used in various minimally invasive surgeries because of their specifications such as their thinness and flexibility, which enables them to be easily inserted into the body to guide larger equipment or instruments such as feeding tubes, catheters, and others. Improvements in surgical procedures and the increasing demand for minimally invasive surgeries is boosting the usage of neurovascular guidewires during minimally invasive interventional procedures.

Rising prevalence of neurovascular diseases is likely to boost the neurovascular guidewires market At present, around 87% of the people worldwide are suffering from stroke, according to the Centers for Disease Control and Prevention. The incidence of ischemic stroke is predicted to increase, especially in the lower to middle-income or underdeveloped countries, according to the World Bank Group. Micro-sensors and fiber optic guidewires improve the results of several surgical procedures, thus broadening the utilization of guidewires from neurovascular diseases to coronary & urological diseases.

Positive outcomes of clinical trials are expected to contribute to the expansion of neurovascular guidewires market Clinical trials have demonstrated the benefits of guidewires such as lubricious coating, sterility, and biocompatibility, efficacy in the treatment procedure of aneurysm, cerebral infarction, and ischemic stroke, which is another factor estimated to the boost the neurovascular guidewires market. The ongoing studies of new technologies to improve the quality of treatment with the help of neuro-intervention procedures, such as a gold coil at the tip for radio capacity and a distal tip that is specially engineered for neuro-intervention procedures, are expected to support the growth of neurovascular guidewires market.